The University of British Columbia’s School of Biomedical Engineering is proud to announce the launch…
karnottMay 29, 2024
Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design…
karnottMay 27, 2024
UBC Medicine researchers Drs. Robert Olson and Bernie Eigl have been honoured by Clinical Trials…
karnottMay 27, 2024
adMare BioInnovations (adMare) is pleased to announce the acceptance of five therapeutics start-ups from across…
karnottMay 24, 2024
Dr. Sally Otto—a theoretical biologist focused on fundamental questions of population genetics and evolution—has been…
karnottMay 24, 2024
High-grade serous ovarian cancer (HGSC) is a challenging disease, especially for patients with immunologically “cold”…
karnottMay 23, 2024
New evidence underscores the importance of conducting follow-up biopsies in children after treatment for rejection…
karnottMay 23, 2024
The effectiveness of radiotherapy depends on the sensitivities of ‘normal’ and cancer cells to the…
karnottMay 22, 2024
An interdisciplinary UBC team led by Dr. Peter Zandstra has received $1.65 million in federal…
karnottMay 22, 2024
